In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) was $7.84 for the day, down -0.38% from the previous closing price of $7.87. In other words, the price has decreased by -$0.38 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
Our analysis of DNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.61.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 25 ’25 when Che Austin bought 99 shares for $7.92 per share.
Che Austin bought 99 shares of DNA for $760 on Apr 24 ’25. On Apr 21 ’25, another insider, Coen Steven P., who serves as the insider of the company, sold 997 shares for $7.28 each. As a result, the insider received 7,261 and left with 8,819 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.00 while its Price-to-Book (P/B) ratio in mrq is 0.56.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $45.20, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is -2.56%, while the 200-Day Moving Average is calculated to be -15.15%.
Shares Statistics:
A total of 42.70M shares are outstanding, with a floating share count of 36.98M. Insiders hold about 32.80% of the company’s shares, while institutions hold 59.26% stake in the company.
